News
Accenture, a global consulting powerhouse, is facing back-to-back slowdowns in new project bookings due to rising ...
Hosted on MSN21d
Watch CNBC's full interview with Accenture CEO Julie Sweet - MSNAccenture's Julie Sweet discusses the growth of AI, macro uncertainty, the UK market and DEI policy Iran’s supreme leader makes first public statement since ceasefire declared in Israel-Iran war ...
In today's job market, mastering AI skills might seem like the golden ticket to getting hired. But at tech consultancy Accenture (NYSE:ACN), CEO Julie Sweet relies on a surprisingly simple ...
When asked by Tangen what Sweet herself had learned in the last six months, the Accenture CEO said it had mostly been around AI. During an investor call in December, Sweet said she had met with 30 ...
In an interview on the In Good Company podcast with Nicolai Tangen, the CEO of Norges Bank Investment Management, Sweet was asked what she looked for when hiring new consultants at the $64 billion ...
Accenture CEO Julie Sweet said that the tightened US federal spending is weighing on its revenue. During the company’s fiscal second-quarter earnings call, Sweet said “As you know, the new ...
Tellingly, new bookings in the recently-ended second fiscal quarter hit $20.3 billion, down 3%. Sweet said this has delayed or ended some contracts managed by Accenture Federal Services.
Hosted on MSN3mon
Accenture CEO Julie Sweet: We feel well-positioned to help the federal gov. achieve their mission - MSNJulie Sweet, Accenture CEO, joins CNBC's 'Squawk on the Street' to discuss the company's most recent quarter, what impact Accenture may experience from DOGE cuts, and more.
Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable condition, she will undergo surgery and radiation treatment while continuing ...
Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...
Today, Accenture plc (NYSE: ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results